42 CFR 121.9
§ 121.9 Designated transplant program requirements.
United States · 42 CFR — Public Health · Status: effective
Cite this
- Citation
- 42 CFR 121.9, § 121.9 Designated transplant program requirements, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/202116
- Permanent ID
ys:prov:202116@1- SHA-256
ee21294ef877920fe0ca626cdd0f29cdfc41bd0e14e74c8f35b5199e778f0edc
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) To receive organs for transplantation, a transplant program in a hospital that is a member of the OPTN shall abide by these rules and shall:
(1) Be a transplant program approved by the Secretary for reimbursement under Medicare; or
(2) Be an organ transplant program which has adequate resources to provide transplant services to its patients and agrees promptly to notify the OPTN and patients awaiting transplants if it becomes inactive and which:
(i) Has letters of agreement or contracts with an OPO;
(ii) Has on site a transplant surgeon qualified in accordance with policies developed under § 121.4;
(iii) Has on site a transplant physician qualified in accordance with policies developed under § 121.4;
(iv) Has available operating and recovery room resources, intensive care resources and surgical beds and transplant program personnel;
(v) Shows evidence of collaborative involvement with experts in the fields of radiology, infectious disease, pathology, immunology, anesthesiology, physical therapy and rehabilitation medicine, histocompatibility, and immunogenetics and, as appropriate, hepatology, pediatrics, nephrology with dialysis capability, and pulmonary medicine with respiratory therapy support;
(vi) Has immediate access to microbiology, clinical chemistry, histocompatibility testing, radiology, and blood banking services, as well as the capacity to monitor treatment with immunosuppressive drugs; and
(vii) Makes available psychiatric and social support services for transplant candidates, transplant recipients, and their families; or
(3) Be a transplant program in a Department of Veterans Affairs, Department of Defense, or other Federal hospital.
(b) To apply to be a designated transplant program, transplant programs shall provide to the OPTN such documents as the OPTN may require which show that they meet the requirements of § 121.9(a) (1), (2), or (3).
(c) The OPTN shall, within 90 days, accept or reject applications to be a designated transplant program.
(d) Applicants rejected for designation may appeal to the Secretary. Appeals shall be submitted in writing within 30 days of rejection of the application. The Secretary may:
(1) Deny the appeal; or
(2) Direct the OPTN to take action consistent with the Secretary's response to the appeal.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.